Cargando…

Anticoagulation, immortality, and observations of COVID‐19

Detalles Bibliográficos
Autores principales:	Maley, Jason H., Petri, Camille R., Brenner, Laura N., Chivukula, Raghu R., Calhoun, Tiara F., Vinarsky, Vladimir, Hardin, Charles Corey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283726/ https://www.ncbi.nlm.nih.gov/pubmed/32685874 http://dx.doi.org/10.1002/rth2.12398

Ejemplares similares

The Fast Literature Assessment and Review (FLARE) Initiative. A Collaborative Effort for Timely Literature Appraisal during the Coronavirus Disease Pandemic
por: Petri, Camille R., et al.
Publicado: (2020)

Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review
por: Hariri, Lida P., et al.
Publicado: (2021)

Reply to Epelbaum: Standards and Stereotypes in COVID-19
por: Ziehr, David R., et al.
Publicado: (2020)

Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: “Typical” or Not?
por: Maley, Jason H., et al.
Publicado: (2020)

Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study
por: Ziehr, David R., et al.
Publicado: (2020)

The Piwi‐piRNA pathway: road to immortality
por: Sturm, Ádám, et al.
Publicado: (2017)

Reply to Yaroshetskiy et al.: Acute Respiratory Distress Syndrome in COVID-19: Do All These Patients Definitely Require Intubation and Mechanical Ventilation?
por: Ziehr, David R., et al.
Publicado: (2020)

Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond
por: Dalager-Pedersen, Michael
Publicado: (2022)

New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins
por: Esmon, Charles T.
Publicado: (2002)

Anticoagulant Rodenticides, Islands, and Animal Welfare Accountancy
por: Fisher, Penny, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Role of anticoagulation in neurological practice
por: Verma, Rajesh
Publicado: (2016)

Adherence to anticoagulation: an ongoing challenge
por: Seelig, J., et al.
Publicado: (2019)

Commentary: “Käytännöllistelemälläkin”: Antiaggregants, anticoagulants, and endocarditis
por: Mennander, Ari A.
Publicado: (2021)

A call to action for anticoagulation stewardship
por: Burnett, Allison E., et al.
Publicado: (2022)

The Immortal Memory of Harvey
por: Underhill, Charles E.
Publicado: (1905)

Endogenous glycosaminoglycan anticoagulation in extracorporeal membrane oxygenation
por: MacLaren, Graeme, et al.
Publicado: (2014)

Oral Anticoagulants and Renal Impairment: The Convoluting Dilemma
por: Serebruany, Victor
Publicado: (2016)

COVID‐19–related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy
por: Assinger, Alice
Publicado: (2021)

Anticoagulant drug‐drug interactions: Highlighting the need for antithrombotic stewardship and shared decision making
por: Vazquez, Sara R., et al.
Publicado: (2022)

Immortality
por: Carroll, John
Publicado: (2020)

Commentary on the 2021 ASH Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Therapeutic Monitoring of Direct Oral Anticoagulants—Back to the Future?
por: Hu, Kai, et al.
Publicado: (2020)

A question is “what are the optimal targets for anticoagulant therapies?”
por: Yokoyama, Nobuyuki, et al.
Publicado: (2020)

Should we treat sepsis-induced DIC with anticoagulants?
por: Inata, Yu
Publicado: (2020)

Are outpatient anticoagulation management services the wave of the future (again)?
por: Samuelson Bannow, Bethany
Publicado: (2022)

Directing Autoimmunity to Nucleoprotein Particles: The Impact of Dendritic Cells and Interferon α in Lupus
por: Hardin, John A.
Publicado: (2003)

Direct oral anticoagulants in extremely obese patients: OK to use?
por: Moll, Stephan, et al.
Publicado: (2018)

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark
por: Klok, Frederikus A., et al.
Publicado: (2020)

Ultrasound-guided truncal/plane blocks: Are they safe in anticoagulated patients?
por: Salhotra, Rashmi
Publicado: (2020)

The Immortal Life of Henrietta Lacks
por: Ciaccia, Laura
Publicado: (2010)

Measuring the anticoagulant effect of low molecular weight heparins in the critically ill
por: Crowther, Mark, et al.
Publicado: (2006)

Regional citrate anticoagulation in patients with liver failure - time for a rethink?
por: Patel, Sameer, et al.
Publicado: (2012)

Perioperative bridging anticoagulation for atrial fibrillation—the first randomised controlled trial
por: Wight, James Matthew, et al.
Publicado: (2016)

An anticoagulant that does not cause bleeding – an abrupt stop on the road to the Holy Grail
por: Meijers, Joost C. M., et al.
Publicado: (2019)

Hematohepatology: The potential for direct oral anticoagulant “Inflation” in liver transplant candidates
por: Schaefer, Jordan K., et al.
Publicado: (2023)

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Triumph of the immortality-will
por: Ludendorff, Mathilde Spiess, 1877-1966
Publicado: (1982)

Immortal DNA
por: Tuma, Rabiya S.
Publicado: (2005)

The immortality enzyme.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_hqs5i51gf4s35h741fmko78j6h